search
Back to results

SHAPE:SeeingtheHeartwithAIPoweredEcho (SHAPE)

Primary Purpose

Cardiac Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Limited Echocardiogram
Sponsored by
Sara Guttas
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Cardiac Disease focused on measuring Disease detection, Medicare aged patients, routine physical examination, primary care, limited echocardiogram

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Patients indicated for a standard physical examination
  2. Patients ≥65 years old

For patients in Phase I, one of the following additional inclusion criteria must be present:

  1. Patient presenting with a new murmur, or history of a murmur but no prior echo within 3 years of the exam
  2. Patient presenting with shortness of breath
  3. Unexplained pedal edema

Exclusion Criteria:

  1. Unable to lie flat for study
  2. Significant anatomical abnormality, recent trauma, or recent thoracic/abdominal surgery that would limit the ability to obtain adequate images
  3. Subjects unwilling or unable to give written informed consent
  4. Patients experiencing a known or suspected acute cardiac event Eligibility criteria for Phases II and III of this study will be finalized once results from Phase I are available. The current plan is to have similar criteria for Phases II and III.

Sites / Locations

  • Northwestern Memorial, Central DuPage

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Medicare Primary Care Provider (PCP) Patients

Arm Description

This is a non-randomized study of non-significant risk (NSR) that will be conducted at Northwestern's Central Dupage Hospital. Medicare patients > 65 years who are scheduled for a routine physical exam with their PCP that meet inclusion and exclusion criteria will be asked to participate in this study. Consenting patients will be scheduled for 2 back to back ultrasound scans including 5 standard 2D echocardiogram views each. The first scan will be performed by a non-ultrasound specialist using EchoGPS experimental guidance technology and the second control exam will be performed by a trained sonographer using a cleared conventional ultrasound platform.

Outcomes

Primary Outcome Measures

% of diagnostic quality clips acquired by a non-specialist using experimental guidance software, with quality assessed using the American College of Emergency Physician (ACEP) Suggested Quality Assurance Grading Scale
All of the echo views (or "clips") acquired by non-specialists during the study will be scored for image quality (IQ) by clinicians using the 1-5 ACEP quality grading scale. In this scale, a score of 1 represents the poorest IQ and 5 the highest. Images must have a score of 3 or higher to be considered diagnostic quality. Diagnostic quality images (3+) meet at least minimal criteria for diagnosis to be supported and are therefore clinically acceptable.

Secondary Outcome Measures

Number of minutes for non-specialists to perform studies using EchoGPS experimental guidance software
Number of minutes for non-specialists to perform studies using EchoGPS software as compared to that of the time for expert sonographer's control studies using FDA 510(k)-cleared, commercially available ultrasound platform. The time of Study Exam will be compared to that of Control Exam on a per subject basis (paired difference) for Phase I of the study.

Full Information

First Posted
October 8, 2018
Last Updated
March 19, 2020
Sponsor
Sara Guttas
search

1. Study Identification

Unique Protocol Identification Number
NCT03705650
Brief Title
SHAPE:SeeingtheHeartwithAIPoweredEcho
Acronym
SHAPE
Official Title
SHAPE: Seeing the Heart With AI Powered Echo
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
October 10, 2018 (Actual)
Primary Completion Date
March 30, 2019 (Actual)
Study Completion Date
September 6, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Sara Guttas

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
Establish transthoracic echocardiogram (TTE) exams performed with Bay Labs EchoGPS guidance technology can be used in a primary care setting to accurately identify cardiac disease. In Phase I TTE exams with EchoGPS will be compared to findings from a commercially available, FDA 510(k)-cleared reference device (Terason uSmart 3200t, point-of-care ultrasound) without EchoGPS assistance technology. Study is non-significant risk (NSR).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Disease
Keywords
Disease detection, Medicare aged patients, routine physical examination, primary care, limited echocardiogram

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
55 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Medicare Primary Care Provider (PCP) Patients
Arm Type
Experimental
Arm Description
This is a non-randomized study of non-significant risk (NSR) that will be conducted at Northwestern's Central Dupage Hospital. Medicare patients > 65 years who are scheduled for a routine physical exam with their PCP that meet inclusion and exclusion criteria will be asked to participate in this study. Consenting patients will be scheduled for 2 back to back ultrasound scans including 5 standard 2D echocardiogram views each. The first scan will be performed by a non-ultrasound specialist using EchoGPS experimental guidance technology and the second control exam will be performed by a trained sonographer using a cleared conventional ultrasound platform.
Intervention Type
Diagnostic Test
Intervention Name(s)
Limited Echocardiogram
Intervention Description
STUDY SOFTWARE non-significant risk (NSR) Bay Labs EchoGPS software interfaced with the Terason uSmart 3200t FDA 510(k)-cleared, commercially available ultrasound EchoGPS software communicates with the ultrasound image formation engine of the 510(k)-cleared Terason uSmart 3200t through an application programming interface (API). EchoGPS will be used to provide visual guidance, feedback and interpretation assistance to users during image acquisition. For this study, CMAs will use EchoGPS to perform point-of-care echocardiogram examinations.
Primary Outcome Measure Information:
Title
% of diagnostic quality clips acquired by a non-specialist using experimental guidance software, with quality assessed using the American College of Emergency Physician (ACEP) Suggested Quality Assurance Grading Scale
Description
All of the echo views (or "clips") acquired by non-specialists during the study will be scored for image quality (IQ) by clinicians using the 1-5 ACEP quality grading scale. In this scale, a score of 1 represents the poorest IQ and 5 the highest. Images must have a score of 3 or higher to be considered diagnostic quality. Diagnostic quality images (3+) meet at least minimal criteria for diagnosis to be supported and are therefore clinically acceptable.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Number of minutes for non-specialists to perform studies using EchoGPS experimental guidance software
Description
Number of minutes for non-specialists to perform studies using EchoGPS software as compared to that of the time for expert sonographer's control studies using FDA 510(k)-cleared, commercially available ultrasound platform. The time of Study Exam will be compared to that of Control Exam on a per subject basis (paired difference) for Phase I of the study.
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients indicated for a standard physical examination Patients ≥65 years old For patients in Phase I, one of the following additional inclusion criteria must be present: Patient presenting with a new murmur, or history of a murmur but no prior echo within 3 years of the exam Patient presenting with shortness of breath Unexplained pedal edema Exclusion Criteria: Unable to lie flat for study Significant anatomical abnormality, recent trauma, or recent thoracic/abdominal surgery that would limit the ability to obtain adequate images Subjects unwilling or unable to give written informed consent Patients experiencing a known or suspected acute cardiac event Eligibility criteria for Phases II and III of this study will be finalized once results from Phase I are available. The current plan is to have similar criteria for Phases II and III.
Facility Information:
Facility Name
Northwestern Memorial, Central DuPage
City
Winfield
State/Province
Illinois
ZIP/Postal Code
60190
Country
United States

12. IPD Sharing Statement

Learn more about this trial

SHAPE:SeeingtheHeartwithAIPoweredEcho

We'll reach out to this number within 24 hrs